Amgen contends with data breach, exposing patient information
Amgen contends with data breach, exposing patient information is a pharma and life sciences industry update from Pharmaceutical Technology. The story may affect commercial strategy, market access planning, stakeholder engagement, competitive positioning, and near-term monitoring for pharmaceutical and biotech teams.
Amgen is investigating the extent of this breach, which has exposed private patient and proprietary information.
Source: Pharmaceutical Technology